Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2017-02-16 17:09:48
Reporting Period:
Filing Date:
Accepted Time:
2017-02-16 17:09:48
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1485003 Eleven Biotherapeutics Inc. EBIO () 4
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1205535 J John Mccabe C/o Eleven Biotherapeutics, Inc.
245 First Street, Suite 1800
Cambridge MA 02142
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-02-14 1,399 $2.10 5,930 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
  1. The shares of common stock underlying the restricted stock units reported as disposed herein were sold by the issuer in satisfaction of tax withholding obligations associated with the vesting of such units.